IBB vs XYLD
iShares Biotechnology ETF vs Global X S&P 500 Covered Call ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
XYLD—
Global X S&P 500 Covered Call ETF
S&P 500 covered call strategy for enhanced income.
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | XYLD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | Global X |
IBB top holdings
Holdings data unavailable for IBB.
XYLD top holdings
Holdings data unavailable for XYLD.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About XYLD
XYLD (Global X S&P 500 Covered Call ETF) is S&P 500 covered call strategy for enhanced income.